Substitutional Hornotherapy in Sexological and Andrological Practices

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Published: Jul 31, 2019
DOI: https://doi.org/10.30841/2307-5090.2.2019.179383
Keywords:
hypogonadism, partial androgen deficiency, hormone replacement therapy,

##plugins.themes.bootstrap3.article.main##

В. В. Спиридоненко
State Institution «Institute of Urology of NAMS of Ukraine», Ukraine

Abstract

Hormone replacement therapy in hypogonadism of different genesis is an effective treatment with the possibility of reversibility of changes in hormonal levels. The earlier the signs of hypogonadism are verified, the more successful will be its correction, the goals of which will also differ depending on the different forms (congenital, acquired) of the given condition. The ultimate goal of adequate correction of hypogonadism of any genesis is to improve the quality of life of the patient, the essence of which in various forms of pathology may be different (improvement of erectile function, of health, of germinative function, prevention of somatic complications with a positive effect on the patient’s mental profile).

##plugins.themes.bootstrap3.article.details##

How to Cite
Спиридоненко, В. В. (2019). Substitutional Hornotherapy in Sexological and Andrological Practices. Health of Man, (2), 6–12. https://doi.org/10.30841/2307-5090.2.2019.179383
Issue
No. 2 (2019)
Section
Distance learning
Copyright (c) 2020 В. В. Спиридоненко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biography

В. В. Спиридоненко, State Institution «Institute of Urology of NAMS of Ukraine»

Volodymyr V. Spyrydonenko

References

Андрология. Мужское здоровье и дисфункция репродуктивной системы (2005) / Под ред. Э. Нишлага, Г.М. Бере: пер. с англ. – М.: Миа. – 551 с.

Древаль А.В. (2001) Основные синдромы при эндокринных болезнях мужских половых желез // Андрология и генитальная хирургия. – № 2. – С. 22–26.

Горпинченко И.И., Гурженко Ю.Н. (2009) Поздний гипогонадизм и Небидо. Вопросы и ответы // Здоровье мужчины. – № 1 (28). – С. 28–36.

Горпинченко И.И., Гурженко Ю.Н. (2010) Поздний гипогонадизм и Небидо. Вопросы и ответы. Монография. – Киев. – 32 с.

Горпинченко I.I., Гурженко Ю.М., Спиридоненко В.В. (2015) Вплив фiтотерапiї на чоловiкiв із сексуальними порушеннями. Методичнi рекомендацii. – Київ. – 32 с.

Гурженко Ю.Н. (2008) Триада: эректильная дисфункция, гипогонадизм и метаболический синдром // Здоровье мужчины. – № 3 (26). – С. 36–42.

Сексология и андрология (1997) Под ред. А.Ф. Возианова, И.И. Горпинченко. – К.: Абрис. – 880 с.

Спиридоненко В.В. (2016) Хронічний калькульозний простатит: етіологія, патогенез, діагностика та сучасні методи лікування // Здоровье мужчины. – № 4 (59). – С. 6–9.

Christopher B. Cutter M.D. (2001) Compounded Percutaneous Testosteron Gel: Use And Effects in hypogonadal men // J. Am Board Fam Pract. 2001; 14 (1): 22–32.

Cruger D. et al. (2001) Birth of a healthy girl ICSI with ejaculated spermatozoa from a man with nonmosaic Klinefelter’s syndrome // Hum. Reprod.; Sept; 16 (9): 1909–1911.

Darby E., Anawalt B.D.(2005) Male hypogonadism: an update on diagnosis and treatment // Treat Endocrinol.; 4 (5): 293–309.

Dode C., Hardelin J.P. (2004) Kallmann syndrome: fibroblast grouth factor: signaling insufficiency? // J. Mol. Med.; Nov; 82 (11): 725–734.

Madgar I. et al. (2002) Prognostic value of the clinical and laboratory evaluation in patients with nonmosaic Klinefelter syndrome who are receiving assisted reproductive therapy // Fertil. Steril. Jun; 77(6): 1167–1169.

Nebido (2004) // Product Monograph, Andrology. August; 59.

Seftel A.D. (2005) Male hypogonadism. Part I: Epidemiology of Hypogonadism // Int. J. Res.; Sept; 29.